Aberrant neurofilament phosphorylation occurs in many neurodegenerative dis
eases, and in this study, two animal models of type 1 diabetes-the spontane
ously diabetic BE rat and the streptozocin-induced diabetic rat-have been u
sed to determine whether such a phenomenon is involved in the etiology of t
he symmetrical sensory polyneuropathy commonly associated with diabetes. Th
ere was a two- to threefold (P < 0.05) elevation of neurofilament phosphory
lation in lumbar dorsal root ganglia (DRG) of diabetic rats that was locali
zed to perikarya of medium to large neurons using immunocytochemistry, Addi
tionally, diabetes enhanced neurofilament M phosphorylation by 2.5-fold (P
< 0.001) in sural nerve of BE rats. Neurofilaments are substrates of the mi
togen-activated protein kinase (MAPK) family, which includes c-jun NH2-term
inal kinase (JNK) or stress-activated protein kinase (SAPK1) and extracellu
lar signal-regulated kinases (ERKs) 1 and 2, Diabetes induced a significant
three- to fourfold (P < 0.05) increase in phosphorylation of a 54-kDa isof
orm of JNK in DRG and sural nerve, and this correlated with elevated c-Jun
and neurofilament phosphorylation, In diabetes, ERK phosphorylation was als
o increased in the DRG, but not in sural nerve. Immunocytochemistry showed
that JNK was present in sensory neuron perikarya and axons, Motoneuron peri
karya and peroneal nerve of diabetic rats showed no evidence of increased n
eurofilament phosphorylation and failed to exhibit phosphorylation of JNK,
It is hypothesized that in sensory neurons of diabetic rats, aberrant phosp
horylation of neurofilament may contribute to the distal sensory axonopathy
observed in diabetes.